The University of Michigan has
launched a three-year research study to understand if data collected on Apple
Watch, combined with other health information, can provide insight into health,
wellness, and disease. The goal of the research study is to understand the role
of wearable mobile devices in predicting the onset of common health conditions
and understanding the health trajectories of participants with these
MIPACT Study Background
study called MIPACT (Michigan Predictive Activity and Clinical Trajectories),
is already underway, with 1,000 participants enrolled with plans to enroll
thousands more patients from its academic medical center over the next year. Participants
will be asked to complete surveys while using an Apple Watch and a blood
pressure monitor for researchers to better understand their overall health and
level of activity.
The resulting data will be made available to participants and
researchers who are studying health information, daily activity, wearable
signals, and participant-reported quality of life with an eye toward an
improved understanding of wellness and disease. Apple is collaborating with U-M
to conduct this study and a subset of the data will be available to Apple
interaction between disease, daily quality of life, and healthcare services are
poorly understood in today’s research. Comprehensive data from electronic health records
(EHR), collected over a long period of time (longitudinal data) can
complement the physiological and lifestyle data derived from the Apple Watch.
In addition, genomic testing can show how inherited traits may contribute to
the development of disease.
data recorded by the Apple Watch, such as step count, heart rate, and other
activity data, provide valuable information that is often missing from research
and quality improvement efforts by healthcare providers.
study is a unique opportunity to work with patients to gain insight into their
daily and overall health status, providing a wealth of data that can be used
for research that benefits everyone and advances health care,” says Marshall S.
Runge, M.D., Ph.D., executive vice president for medical affairs and dean of
the U-M Medical School.
study is sponsored, in part, by Apple Inc., who is providing partial financial
support and materials for the study.